Home >> Research Area >>Natural Products>>Flavonoids>> Euchrestaflavanone B

Euchrestaflavanone B

CAS# 87402-91-3

Euchrestaflavanone B

Catalog No. BCN6838----Order now to get a substantial discount!

Product Name & Size Price Stock
Euchrestaflavanone B: 5mg $903 In Stock
Euchrestaflavanone B: 10mg Please Inquire In Stock
Euchrestaflavanone B: 20mg Please Inquire Please Inquire
Euchrestaflavanone B: 50mg Please Inquire Please Inquire
Euchrestaflavanone B: 100mg Please Inquire Please Inquire
Euchrestaflavanone B: 200mg Please Inquire Please Inquire
Euchrestaflavanone B: 500mg Please Inquire Please Inquire
Euchrestaflavanone B: 1000mg Please Inquire Please Inquire

Quality Control of Euchrestaflavanone B

Number of papers citing our products

Chemical structure

Euchrestaflavanone B

3D structure

Chemical Properties of Euchrestaflavanone B

Cas No. 87402-91-3 SDF Download SDF
PubChem ID 14542254 Appearance Powder
Formula C25H28O6 M.Wt 424.49
Type of Compound Flavonoids Storage Desiccate at -20°C
Solubility Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
Chemical Name (2S)-2-[2,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-8-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one
SMILES CC(=CCC1=C(C=C(C(=C1)C2CC(=O)C3=C(O2)C(=C(C=C3O)O)CC=C(C)C)O)O)C
Standard InChIKey IPNPAENNCXAVSJ-QHCPKHFHSA-N
Standard InChI InChI=1S/C25H28O6/c1-13(2)5-7-15-9-17(20(28)10-18(15)26)23-12-22(30)24-21(29)11-19(27)16(25(24)31-23)8-6-14(3)4/h5-6,9-11,23,26-29H,7-8,12H2,1-4H3/t23-/m0/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Source of Euchrestaflavanone B

The root barks of Cudrania tricuspidata.

Biological Activity of Euchrestaflavanone B

Description1. Euchrestaflavanone B may function by inhibiting oncogenic disease, at least in part, through the inhibition of protein kinase CKII activity. 2. Euchrestaflavanone B shows antibacterial activity against Gram positive bacteria, Staphylococcus aureus, Bacillus subtilis and Bacillus cereus.
TargetsPARP | Antifection

Euchrestaflavanone B Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Euchrestaflavanone B Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Euchrestaflavanone B

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.3558 mL 11.7788 mL 23.5577 mL 47.1154 mL 58.8942 mL
5 mM 0.4712 mL 2.3558 mL 4.7115 mL 9.4231 mL 11.7788 mL
10 mM 0.2356 mL 1.1779 mL 2.3558 mL 4.7115 mL 5.8894 mL
50 mM 0.0471 mL 0.2356 mL 0.4712 mL 0.9423 mL 1.1779 mL
100 mM 0.0236 mL 0.1178 mL 0.2356 mL 0.4712 mL 0.5889 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on Euchrestaflavanone B

Inhibition of protein kinase CKII activity by euchrestaflavanone B purified from Cudrania tricuspidata.[Pubmed:16408697]

Oncol Res. 2005;15(6):327-32.

The CKII (EC 2.7.1.37) inhibitory compound was purified from the root barks of Cudrania tricuspidata and identified as (2S)-2-[2,4-dihydroxy-5-(3-methyl-but-2-enyl)-phenyl]-5,7-dihyroxy-6-(3-methyl-bu t-2-enyl)chroman-4-one (Euchrestaflavanone B). Euchrestaflavanone B was shown to inhibit the phosphotransferase activity of CKII with IC50 of about 78 microM. Steady-state studies revealed that Euchrestaflavanone B acted as a competitive inhibitor with respect to the substrate ATP. A value of 16.4 microM was obtained for the apparent Ki. Concentration of 0.8 microM Euchrestaflavanone B caused 50% growth inhibition of human cancer cells U937 and HeLa. Euchrestaflavanone B-induced cell death was characterized with the cleavage of poly(ADP-ribose) polymerase and procaspase-3, indicating that the inhibitor triggered apoptosis. Because protein kinase CKII is involved in cell proliferation and oncogenesis, these results suggest that Euchrestaflavanone B may function by inhibiting oncogenic disease, at least in part, through the inhibition of CKII activity.

Keywords:

Euchrestaflavanone B,87402-91-3,Natural Products, buy Euchrestaflavanone B , Euchrestaflavanone B supplier , purchase Euchrestaflavanone B , Euchrestaflavanone B cost , Euchrestaflavanone B manufacturer , order Euchrestaflavanone B , high purity Euchrestaflavanone B

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: